Speeches by Ahmed.

“The hon. Member is absolutely right: we need to unblock some of the referral pipelines between GPs and pharmacies. We are absolutely clear in our instructions to the system that pharmacies are an integral and growing component of primary care provision, and that premise underlies all our discussions with pharmacies and…”

“I can reassure the hon. Member that my hon. Friend the Minister for Care is looking at funding and primary care provision in the round in coastal and poorer communities, and I would be delighted to take back his representations about Pharmacy First in rural settings.”

“As the hon. Gentleman will know—or should know—the current remuneration method was agreed in conjunction with the sector. The adjustment was agreed with the sector’s representative body, Community Pharmacy England. Advance notice of the change was provided to those contractors by letter and in an article published by t…”

“My hon. Friend is absolutely right. Independent prescribers are a key and expanding part of our workforce, providing a sustainable primary care service. I am very happy for the Minister for Care to write to him with the exact funding plans for the next financial year.”

“I can assure the hon. Lady of our commitment to an effective primary care system up and down the country, in both rural and coastal communities. My hon. Friend the Minister for Care, whose portfolio includes pharmacy, takes his responsibilities seriously and is exploring all avenues to ensure equity of access and fundi…”

“I am reminded that Liberal Democrat Front Benchers always welcome funding for the NHS, but can never explain where the money should come from. I have already mentioned the record funding that we are putting into pharmacy. I have reiterated that there is ministerial engagement with the pharmacy sector—not just through t…”

“Pharmacy First is indeed a great initiative. It is not the first in this country; it has been developed in other parts of the country. When we came into office, we worked with the sector and stakeholders, and agreements on remuneration and pricing were reached in conjunction with the sector. What is more, we are addres…”

“The hon. Gentleman is absolutely right: we need to unblock the referral pathways. The neighbourhood health service is all about ensuring that the process between general practitioner and pharmacist feels seamless. On payments, we are cognisant of the fact that as demographics change, population needs in different parts…”

“The hon. Member is right that under the Pharmacy First programme, contractors receive a monthly fixed payment upon delivering a minimum number of consultations, as per the 2025-26 agreement. That can go up and down month to month, in a dynamic process, depending on how many patients are seen in pharmacies. I completely…”

“I thank my hon. Friend for all her advocacy on behalf of all her constituents, but particularly Amani’s family. This is a story with which I am very familiar, and I can reassure my hon. Friend that I am committed to ensuring that medical research is properly funded so that, indeed, it is not the duty of bereaved parent…”

“Certainly.”

“I could not agree more with my hon. Friend, and that is why NIHR funding has been specifically allocated. One of the tests for a grant is the diversity of the population it will serve. We recognise the challenges presented by brain tumours. By publishing regular performance data at a more granular level and adding diag…”

“Sacking people is above my pay grade, so I will revert to the Secretary of State’s opinion on that, but my hon. Friend can certainly be reassured that we will hold them accountable, just as she will hold me accountable. She might give me the sack at this rate, so I had better be careful. We are grateful for the continu…”

“I start by thanking my hon. Friend the Member for Mitcham and Morden (Dame Siobhain McDonagh), and the hon. Members for Witney (Charlie Maynard) and for Kingswinford and South Staffordshire (Mike Wood) for supporting this important debate. I would like to take a few moments to acknowledge the contributions of all hon. …”

“I am grateful to the right hon. Member for his remarks. At the risk of turning this into some sort of medical journal club—I will move on quite swiftly, Madam Deputy Speaker—let me point out that the association is based on retrospective data, and we all know that we have to be a little bit cautious with retrospective …”

“I am hearing my hon. Friend’s call to action loud and clear. I can report to her that—this is in addition to the other ongoing clinical trials in the area of brain tumour and glioma research—in October 2025, RECURRENT-GB opened for recruitment. This is a new UK multi-centre randomised controlled trial, supported by nea…”

“I am happy to write to the hon. Lady to give her a fuller answer. She knows that procurement in different parts of the NHS rightly reflects local clinical practices, although there are overarching national frameworks for buying such products. Innovation lends itself to the fact that, over time, patients will want to ch…”

“The anticipation would be that post-market surveillance will continue if devices are still used in a clinical setting. PMS supports UK attractiveness by strengthening confidence in the market for patients, clinicians and investors, and by resourcing a more risk-proportionate, innovation-friendly approach to regulation,…”

“As the hon. Lady knows, doctors are able, in certain circumstances, to prescribe unlicensed treatments to their patients if they feel it is a proportionate act to take. It is not something that is in guidelines or routinely recommended, but is at times at the discretion of individual clinicians. Clearly, that would be …”

“I turn first to the Opposition spokesperson, the hon. Member for Sleaford and North Hykeham. Like me, she is a scholar of medicine, and she practiced in the NHS throughout all 14 years of the last Government. She will know, possibly at first hand, that the MHRA as a regulatory body has not been fit for purpose for a lo…”